Anugerah 88 Logo
$48.53-0.10|(-0.21%)
52W H: 72.3652W L: 19.65Beta: 0.82

About AnaptysBio Inc

Frequently Asked Questions

What is the 52-week range for ANAB?

The 52-week high is $72.36 and the 52-week low is $19.65.

What is the P/E ratio for ANAB?

The Price to Earnings (P/E) ratio is 7.46.

What is the dividend yield for ANAB?

This company does not currently pay a dividend or the data is unavailable.

What is the Return on Equity (ROE)?

The trailing twelve months (TTM) Return on Equity is 894.97%.

What is the Net Profit Margin?

The Net Profit Margin (TTM) is 82.37%.

What is the Price to Book (P/B) Ratio?

The annual Price to Book ratio stands at 188.81.

Analyst Recommendation Trends

Wall Street analyst consensus for ANAB over the last few months:

2026-09-01
Buy: 10
S.Buy: 6
Hold: 1
Sell: 0
2026-08-01
Buy: 10
S.Buy: 6
Hold: 1
Sell: 0
2026-07-01
Buy: 10
S.Buy: 6
Hold: 1
Sell: 0
2026-06-01
Buy: 10
S.Buy: 6
Hold: 1
Sell: 0

Latest ANAB News

JP Morgan Maintains Overweight on AnaptysBio, Lowers Price Target to $60

JP Morgan analyst Anupam Rama maintains AnaptysBio (NASDAQ:ANAB) with a Overweight and lowers the price target from $70 to $60.

Benzinga9/30/2026

AnaptysBio (ANAB) Is Down 7.6% After Tax-Driven Earnings Surge Masks Underlying Cash Performance

AnaptysBio, Inc. previously reported fourth-quarter and six-month 2026 results showing net income of US$183.88 million for the quarter and US$131 million for the half-year, with basic earnings per share from continuing operations rising to US$6.06 for the quarter and US$6.09 for the six months. A key driver of the very large reported profit was a US$181.5 million income-tax benefit from releasing a deferred-tax valuation allowance following the separation of First Tracks Biotherapeutics, an...

Yahoo9/26/2026

AnaptysBio (ANAB) Reports a Tax-Driven Profit. When Will Royalties Fund Shareholder Returns?

AnaptysBio, Inc. (NASDAQ:ANAB) reported $176.4 million of income from continuing operations for the six months ended June 30 in results released September 21. A $181.5 million income-tax benefit, primarily from releasing a deferred-tax valuation allowance, turned a $5.1 million pretax loss into that profit. The tax adjustment reflects greater expected use of tax assets following […]

Yahoo9/26/2026

HC Wainwright & Co. Reiterates Buy on AnaptysBio, Maintains $95 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates AnaptysBio (NASDAQ:ANAB) with a Buy and maintains $95 price target.

Benzinga9/24/2026

Leerink Partners Maintains Outperform on AnaptysBio, Lowers Price Target to $81

Leerink Partners analyst David Risinger maintains AnaptysBio (NASDAQ:ANAB) with a Outperform and lowers the price target from $90 to $81.

Benzinga9/23/2026

AnaptysBio, Inc. (ANAB) Reports Q2 Loss, Tops Revenue Estimates

AnaptysBio (ANAB) delivered earnings and revenue surprises of +76.09% and +3.03%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Yahoo9/21/2026

Top movers in Monday's after hours session

The US market regular session of Monday is over, let's have a look at the top gainers and losers in the after hours session today.

ChartMill9/21/2026

Anaptys Announces Second Quarter and Transitional Fiscal Year 2026 Financial Results and Provides Business Update

Jemperli global net sales of $644 million (£480 million) for the six months ended June 30, 2026, representing 34% year-over-year growthPositive interim results from the pivotal AZUR-1 trial of Jemperli in untreated stage II/III dMMR/MSI-H locally advanced rectal cancer announced in July; FDA PDUFA action date of February 2027 with eligibility for expedited review through the National Priority Voucher program, which could result in an earlier FDA decisionLitigation with GSK and Tesaro: trial held

Yahoo9/21/2026

12 Health Care Stocks Moving In Monday's After-Market Session

Gainers Milestone Scientific (AMEX:MLSS) stock moved upwards by 11.8% to $0.44 during Monday's after-market session. The company's market cap stands at $36.9 million. Evotec (NASDAQ:EVO) stock rose 8.44% to

Benzinga9/21/2026

AnaptysBio Q2 Adj. EPS $(0.11) Beats $(0.46) Estimate, Sales $27.488M Beat $21.675M Estimate

AnaptysBio (NASDAQ:ANAB) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.46) by 76.09 percent. This is a 91.79 percent increase over losses of $(1.34) per share from the

Benzinga9/21/2026

Alphyn Capital on Its Special-Situation Investment: AnaptysBio (ANAB)

Alphyn Capital Management, an investment management firm, released its second-quarter 2026 investor letter. The letter can be downloaded here. The fund’s Master Account returned 0.6% net in the quarter compared to 15.2% for the S&P500. As of June 30, 2026, the top ten positions comprised approximately 72% of the portfolio, and the portfolio held approximately […]

Yahoo9/9/2026

Related Stocks (Peers)

Companies operating in similar sectors to ANAB:

XNCRSNDXTSHARARECOAGANABINBXTYRAAVBPKLRA1228.HK950160.KQ

Recent Insider Transactions

DateNameShares ChangedPriceValue
2026-09-15Orwin John A-1,300--
2026-09-15Orwin John A+1,300--
2026-06-15Schmid John P.-6,030--
2026-06-15Schmid John P.+6,030--
2026-06-15Orwin John A-6,030--
2026-06-15Orwin John A+6,030--
2026-06-15RENTON HOLLINGS-6,030--
2026-06-15RENTON HOLLINGS+6,030--
2026-05-11Murphy Christopher M.+25,765--
2026-05-11Hughes Owen+11,250--
2026-04-27GRAY SUSANNAH+11,250--
2026-04-20Faga Daniel-11,000--
2026-04-20Faga Daniel+133,400--
2026-04-20Faga Daniel-133,400--
2026-04-20Faga Daniel+305,500--
2026-04-20Faga Daniel-305,500--
2026-04-20Faga Daniel+379,620--
2026-04-20Faga Daniel-379,620--
2026-04-20Faga Daniel+194,900--
2026-04-20Faga Daniel-194,900--
2026-04-20Faga Daniel+9,200--
2026-04-20Faga Daniel-9,200--
2026-04-20Faga Daniel+2,321--
2026-04-20Faga Daniel-2,321--
2026-04-20Faga Daniel+11,000--
2026-04-20Faga Daniel-11,000--
2026-04-20Schmid John P.+5,500--
2026-04-20Schmid John P.-5,500--
2026-04-20Schmid John P.+16,510--
2026-04-20Schmid John P.-16,510--
2026-04-20Schmid John P.+16,510--
2026-04-20Schmid John P.-16,510--
2026-04-20Schmid John P.+10,600--
2026-04-20Schmid John P.-10,600--
2026-04-20Schmid John P.+9,200--
2026-04-20Schmid John P.-9,200--
2026-04-20Schmid John P.+11,000--
2026-04-20Schmid John P.-11,000--
2026-04-20Schmid John P.+11,000--
2026-04-20Schmid John P.-11,000--
2026-04-20Schmid John P.+6,000--
2026-04-20Schmid John P.-6,000--
2026-04-20Schmid John P.+6,000--
2026-04-20Schmid John P.-6,000--
2026-04-20Schmid John P.+15,000--
2026-04-20Schmid John P.-15,000--
2026-04-20Orwin John A+8,250--
2026-04-20Orwin John A-8,250--
2026-04-20Orwin John A+16,510--
2026-04-20Orwin John A-16,510--
2026-04-20Orwin John A+16,510--
2026-04-20Orwin John A-16,510--
2026-04-20Orwin John A+10,600--
2026-04-20Orwin John A-10,600--
2026-04-20Orwin John A+3,311--
2026-04-20Orwin John A-3,311--
2026-04-20RENTON HOLLINGS+5,500--
2026-04-20RENTON HOLLINGS-5,500--
2026-04-20RENTON HOLLINGS+16,510--
2026-04-20RENTON HOLLINGS-16,510--
2026-04-20RENTON HOLLINGS+16,510--
2026-04-20RENTON HOLLINGS-16,510--
2026-04-20RENTON HOLLINGS+10,600--
2026-04-20RENTON HOLLINGS-10,600--
2026-04-20RENTON HOLLINGS+9,200--
2026-04-20RENTON HOLLINGS-9,200--
2026-04-20RENTON HOLLINGS+11,000--
2026-04-20RENTON HOLLINGS-11,000--
2026-04-20RENTON HOLLINGS+11,000--
2026-04-20RENTON HOLLINGS-11,000--
2026-04-20RENTON HOLLINGS+6,000--
2026-04-20RENTON HOLLINGS-6,000--
2026-04-20RENTON HOLLINGS+6,000--
2026-04-20RENTON HOLLINGS-6,000--
2026-04-20RENTON HOLLINGS+15,000--
2026-04-20RENTON HOLLINGS-15,000--
2026-03-30Schmid John P.-522$57.3989$29,962
2026-03-30Schmid John P.-7,527$56.7002$426,782
2026-03-30Schmid John P.-12,596$55.7087$701,707
2026-03-27Faga Daniel-100$65.99$6,599
2026-03-27Faga Daniel-3,038$65.1982$198,072
2026-03-27Faga Daniel-3,155$64.1909$202,522
2026-03-27Faga Daniel-2,592$63.3503$164,204
2026-03-27Faga Daniel-1,012$62.1525$62,898
2026-03-27Faga Daniel-550$60.6264$33,345
2026-03-27Faga Daniel-490$59.6237$29,216
2026-03-27Faga Daniel-3,662$58.6158$214,651
2026-03-27Faga Daniel-2,570$57.9063$148,819
2026-03-27Faga Daniel-510$56.613$28,873
2026-03-25Faga Daniel+34,300--
2026-03-12Lizzul Paul F.+16,667--
2026-03-12Faga Daniel+53,334--
2026-02-11LOUMEAU ERIC J-10,000--
2026-02-11LOUMEAU ERIC J-10,000$54$540,000
2026-02-11LOUMEAU ERIC J+10,000$29.7$297,000
2026-01-15Marquet Magda-11,000--
2026-01-15Marquet Magda-1,710$48.849$83,532
2026-01-15Marquet Magda-9,290$48.1162$446,999
2026-01-15Marquet Magda+11,000$26.11$287,210
2026-01-08Lizzul Paul F.-3,650$44.71$163,192
2026-01-08Faga Daniel-14,281$44.71$638,504
2026-01-08MULROY DENNIS-2,515$44.71$112,446
2026-01-08LOUMEAU ERIC J-2,210$44.71$98,809
2026-01-07Lizzul Paul F.-8,525--
2026-01-07Lizzul Paul F.+8,525--
2026-01-07Faga Daniel-26,838--
2026-01-07Faga Daniel+26,838--
2026-01-07MULROY DENNIS-6,700--
2026-01-07MULROY DENNIS+6,700--
2026-01-07LOUMEAU ERIC J-5,888--
2026-01-07LOUMEAU ERIC J+5,888--
2026-01-07Lizzul Paul F.-2,235$45.11$100,821
2026-01-07Faga Daniel-9,202$45.11$415,102
2026-01-07MULROY DENNIS-1,908$45.11$86,070
2026-01-07LOUMEAU ERIC J-500$47.23$23,615
2026-01-07LOUMEAU ERIC J-1,841$46.1301$84,926
2026-01-07LOUMEAU ERIC J-5,281$45.3839$239,672
2026-01-07LOUMEAU ERIC J-2,017$45.11$90,987
2026-01-06Ware J. Anthony+4,000--
2026-01-06Ware J. Anthony+5,500--
2026-01-06Lizzul Paul F.+29,000--
2026-01-06Lizzul Paul F.+21,400--
2026-01-06Lizzul Paul F.-6,145--
2026-01-06Lizzul Paul F.+6,145--
2026-01-06Jain Rita+4,000--
2026-01-06Jain Rita+5,500--
2026-01-06Faga Daniel+133,400--
2026-01-06Faga Daniel+98,600--
2026-01-06Faga Daniel-17,850--
2026-01-06Faga Daniel+17,850--
2026-01-06Marquet Magda+4,000--
2026-01-06Marquet Magda+5,500--
2026-01-06Schmid John P.+4,000--
2026-01-06Schmid John P.+5,500--
2026-01-06Orwin John A+6,000--
2026-01-06Orwin John A+8,250--
2026-01-06MULROY DENNIS+29,000--
2026-01-06MULROY DENNIS+21,400--
2026-01-06MULROY DENNIS-5,245--
2026-01-06MULROY DENNIS+5,245--
2026-01-06LOUMEAU ERIC J+23,200--
2026-01-06LOUMEAU ERIC J+17,100--
2026-01-06LOUMEAU ERIC J-5,545--
2026-01-06LOUMEAU ERIC J+5,545--
2026-01-06RENTON HOLLINGS+4,000--
2026-01-06RENTON HOLLINGS+5,500--
2026-01-06FENTON DENNIS M+4,000--
2026-01-06FENTON DENNIS M+5,500--
2026-01-05Lizzul Paul F.-4,219$43.26$182,514
2026-01-05Faga Daniel-15,309$43.26$662,267
2026-01-05MULROY DENNIS-3,363$43.26$145,483
2026-01-05LOUMEAU ERIC J-2,983$43.26$129,045
2026-01-03Lizzul Paul F.-10,555--
2026-01-03Lizzul Paul F.+10,555--
2026-01-03Faga Daniel-34,677--
2026-01-03Faga Daniel+34,677--
2026-01-03MULROY DENNIS-8,292--
2026-01-03MULROY DENNIS+8,292--
2026-01-03LOUMEAU ERIC J-7,287--
2026-01-03LOUMEAU ERIC J+7,287--
2025-12-23Ware J. Anthony-3,900$49.575$193,343
2025-12-23Schmid John P.-11,068$51$564,468
2025-12-22Lizzul Paul F.-1,500--
2025-12-22Lizzul Paul F.-1,500$50$75,000
2025-12-22Lizzul Paul F.+1,500$18.5$27,750
2025-12-22MULROY DENNIS-10,000--
2025-12-22MULROY DENNIS-10,000$50$500,000
2025-12-22MULROY DENNIS+10,000$20.16$201,600
2025-12-22LOUMEAU ERIC J-10,000--
2025-12-22LOUMEAU ERIC J-10,000$51$510,000
2025-12-22LOUMEAU ERIC J+10,000$14.02$140,200
2025-12-18LOUMEAU ERIC J-141$46.99$6,626
2025-12-17LOUMEAU ERIC J-10,000--
2025-12-17LOUMEAU ERIC J-10,000$46$460,000
2025-12-17LOUMEAU ERIC J+10,000$14.02$140,200
2025-12-16MULROY DENNIS-10,000--
2025-12-16MULROY DENNIS-6,360$45.2062$287,511
2025-12-16MULROY DENNIS-9,365$44.6152$417,821
2025-12-16MULROY DENNIS+10,000$20.16$201,600
2025-12-16LOUMEAU ERIC J-7,500--
2025-12-16LOUMEAU ERIC J-5,000--
2025-12-16LOUMEAU ERIC J-4,195$45.2369$189,769
2025-12-16LOUMEAU ERIC J-8,305$44.6756$371,031
2025-12-16LOUMEAU ERIC J+7,500$20.16$151,200
2025-12-16LOUMEAU ERIC J+5,000$14.02$70,100